V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003409 | 210006753 | null | null | null | 2018-08-19 | 2018-09-04 | Capecitabine | 02 | null | PACLITAXEL + TRASTUZUMAB | 100707871 |
| 210003414 | 210006757 | null | null | null | null | 2017-01-22 | null | N | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101470279 |
| 210003415 | 210006758 | 1.57 | 52.6 | Palliative (P) | null | 2017-03-27 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100289053 |
| 210003416 | 210006759 | 1.7 | 76.4 | Palliative (P) | 2019-11-05 | 2019-11-26 | EC | 01 | N | EC | 101247313 |
| 210003421 | 210006762 | 1.55 | 85.3 | Palliative (P) | null | 2019-11-26 | FEC 100 | N | N | FEC | 101291223 |
| 210003422 | 210006763 | 1.61 | 60.1 | null | 2016-02-03 | 2016-02-27 | FEC + DOCETAXEL | N | null | FEC + DOCETAXEL | 100481615 |
| 210003423 | 210006764 | 1.49 | 60.5 | Adjuvant (A) | 2018-05-21 | 2018-05-21 | Fulvestrant + Palbociclib | N | N | CAPECITABINE | 100293313 |
| 210003426 | 210006767 | null | null | null | null | 2018-05-24 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101846842 |
| 210003429 | 210006770 | 1.62 | 85.95 | Palliative (P) | null | 2016-12-01 | Capecitabine | 02 | N | LETROZOLE + PALBOCICLIB | 100147183 |
| 210003435 | 210006776 | 1.54 | 0 | Palliative (P) | 2017-01-24 | 2017-02-19 | null | null | N | LETROZOLE + PALBOCICLIB | 101535177 |
| 210003437 | 210006778 | 1.51 | 76.2 | null | 2016-08-21 | 2016-08-29 | EC | null | null | EC | 100114068 |
| 210003438 | 210006779 | null | 95 | null | 2018-11-03 | 2018-11-18 | FEC + DOCETAXEL | null | null | FEC + DOCETAXEL | 100303336 |
| 210003439 | 210006780 | null | null | null | 2016-06-22 | 2016-07-13 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 100457558 |
| 210003440 | 210006781 | 1.76 | 38.4 | Palliative (P) | null | 2018-01-24 | EC | N | N | EC | 101566652 |
| 210003441 | 210006782 | null | null | null | 2016-08-22 | 2016-08-23 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100546728 |
| 210003445 | 210006786 | 1.58 | 106.4 | Palliative (P) | null | 2016-08-19 | Capecitabine | null | N | CAPECITABINE | 101866837 |
| 210003447 | 210006787 | null | null | null | 2019-08-22 | 2019-08-28 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101426523 |
| 210003448 | 210006788 | null | 66.1 | null | null | 2019-07-25 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 101015591 |
| 210003449 | 210006789 | 1.58 | 0 | Palliative (P) | 2020-01-05 | 2020-01-10 | EC | null | N | EC | 100247069 |
| 210003452 | 210006792 | null | null | null | 2017-02-04 | 2017-02-20 | EC | 02 | null | EC | 101775997 |
| 210003453 | 210006793 | 1.72 | 63.95 | 02 | 2014-03-12 | 2014-04-02 | FEC 60 or 75 | 02 | N | FEC | 100102537 |
| 210003454 | 210006794 | null | null | null | 2017-08-02 | 2017-08-17 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100587177 |
| 210003455 | 210006795 | null | 82.3 | null | 2018-06-06 | 2018-06-06 | Epirubicin (weekly) | 01 | null | CARBOPLATIN + PACLITAXEL | 101287174 |
| 210003457 | 210006796 | 1.65 | 75.4 | null | 2019-10-12 | 2019-10-14 | FEC | N | null | TRIAL UNSPECIFIED | 100233095 |
| 210003458 | 210006797 | 1.7 | 79 | Adjuvant (A) | 2017-11-14 | 2017-12-05 | FEC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100518706 |
| 210003460 | 210006799 | null | null | null | 2018-11-11 | 2018-11-19 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101755372 |
| 210003464 | 210006802 | null | null | null | 2018-06-02 | 2018-06-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101854779 |
| 210003466 | 210006804 | 1.68 | null | Neo-adjuvant (N) | 2019-10-26 | 2019-11-21 | EC | null | N | EC | 100042368 |
| 210003467 | 210006805 | 1.47 | 55 | null | 2017-01-16 | 2017-01-31 | Palbociclib | 02 | null | CARBOPLATIN + PEMETREXED | 101178524 |
| 210003468 | 210006806 | 1.72 | 76.9 | Palliative (P) | null | 2018-05-18 | FEC 100 | N | N | FEC | 100903040 |
| 210003470 | 210006808 | null | 88.35 | Palliative (P) | 2015-09-30 | 2015-10-15 | FEC 100 | 02 | null | FEC | 101645975 |
| 210003471 | 210006809 | 1.65 | 73 | Adjuvant (A) | null | 2017-03-12 | PACLITAXEL + TRASTUZUMAB | 02 | N | PACLITAXEL + TRASTUZUMAB | 100558104 |
| 210003472 | 210006810 | 1.53 | 55.4 | null | null | 2017-01-27 | null | null | null | ABEMACICLIB + FULVESTRANT | 101457043 |
| 210003478 | 210006814 | 1.62 | 55 | null | 2016-03-12 | 2016-03-27 | FEC + DOCETAXEL | 02 | null | FEC + DOCETAXEL | 100612533 |
| 210003479 | 210006815 | null | 85.2 | null | 2016-06-28 | 2016-07-13 | null | null | null | CONCEPT TRIAL | 101047420 |
| 210003482 | 210006817 | 1.58 | 86.4 | Neo-adjuvant (N) | null | 2017-10-23 | Palbociclib | 02 | N | CISPLATIN + PACLITAXEL | 100332242 |
| 210003483 | 210006818 | 1.66 | null | Palliative (P) | null | 2020-10-30 | null | N | N | CARBOPLATIN + DOCETAXEL | 100054786 |
| 210003486 | 210006821 | null | null | null | 2017-05-16 | 2017-05-20 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 101627938 |
| 210003488 | 210006822 | null | null | null | 2016-06-15 | 2018-05-30 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100619331 |
| 210003493 | 210006826 | 1.55 | 71.5 | Palliative (P) | 2020-06-14 | 2020-06-14 | ATEZOLIZUMAB + NAB PACLITAXEL | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101844490 |
| 210003495 | 210006827 | 1.55 | 96 | Palliative (P) | 2017-06-17 | 2017-06-23 | FEC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100170841 |
| 210003496 | 210006828 | 1.69 | 71.1 | Adjuvant (A) | 2018-02-28 | 2018-03-01 | FEC 60 or 75 | null | N | FEC | 100591109 |
| 210003501 | 210006831 | 1.61 | 77.6 | Adjuvant (A) | 2016-06-19 | 2016-08-29 | EC | 02 | N | EC | 101043228 |
| 210003503 | 210006833 | null | null | null | 2017-02-18 | 2017-02-27 | Ribociclib | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101800823 |
| 210003504 | 210006834 | 1.52 | 76.9 | Palliative (P) | 2018-03-06 | 2018-03-23 | EC | 02 | N | EC | 101572966 |
| 210003506 | 210006835 | 1.63 | 67.4 | Adjuvant (A) | null | 2018-07-07 | CARBOPLATIN + PACLITAXEL | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100935051 |
| 210003508 | 210006837 | 1.52 | 134.5 | Adjuvant (A) | 2018-02-28 | 2018-03-20 | Liposomal Doxorubicin (Caelyx) | 02 | N | CAPECITABINE | 101369033 |
| 210003509 | 210006838 | null | null | null | 2019-10-09 | 2019-10-15 | ROSCO Trial | N | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100080367 |
| 210003511 | 210006839 | 1.66 | 92.1 | Palliative (P) | 2017-10-04 | 2017-10-24 | FEC | 02 | null | FEC | 101358189 |
| 210003515 | 210006842 | 1.55 | 77.8 | Adjuvant (A) | 2018-09-14 | 2018-09-21 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100708990 |